INS and neuropathy: Different from high-dose STZ injection, which completely induces beta-cell impairment, low-dose STZ injection modestly injures beta-cells, in which the serum insulin is maintained at a medium level (Figure 1L), and T2DM is stable without an insulin intake requirement (46), that is suitable for studies on diabetic complications including neuropathy (29).